Measles virus vaccine attenuation: Suboptimal infection of lymphatic tissue and tropism alteration

Journal of Infectious Diseases

Volumn 196, Issue 4, 2007, Pages 541-549

  Condack, Cristian ^a   Grivel, Jean Charles ^a,c   Devaux, Patricia ^b   Margolis, Leonid ^a   Cattaneo, Roberto ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD150 ANTIGEN; CD45RA ANTIGEN; L SELECTIN; LIVE VACCINE; MEASLES VACCINE; MEMBRANE COFACTOR PROTEIN; VIRUS RECEPTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SYNTHESIS; HUMAN; HUMAN TISSUE; LYMPHOID TISSUE; MACROPHAGE; MEASLES VIRUS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS REPLICATION; VIRUS STRAIN; WILD TYPE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD46; B-LYMPHOCYTES; CALLITHRIX; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; HUMANS; IMMUNOLOGIC MEMORY; KILLER CELLS, NATURAL; MACROPHAGES; MEASLES; MEASLES VACCINE; MEASLES VIRUS; RECEPTORS, CELL SURFACE; RECEPTORS, VIRUS; T-LYMPHOCYTES; TONSIL; VACCINES, ATTENUATED; VERO CELLS; VIRUS REPLICATION;

EID: 34547633342     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/519689     Document Type: Article

References (46)

1. Stein CE, Birmingham M, Kurian M, Duclos P, Strebel P. The global burden of measles in the year 2000 - a model that uses country-specific indicators. J Infect Dis 2003; 187(Suppl 1):S8-14.
2. Griffin DE. Measles virus. In: Knipe DM, Howley PM, eds. Fields virology. 4th ed. Vol. 1. Philadelphia: Lippincott, Williams & Wilkins, 2001:1401-41.
3. Moss WJ, Ota MO, Griffin DE. Measles: immune suppression and immune responses. Int J Biochem Cell Biol 2004; 36:1380-5.
4. Schneider-Schaulies S, Klagge IM, ter Meulen V. Dendritic cells and measles virus infection. Curr Top Microbiol Immunol 2003; 276:77-101.
5. Auwaerter PG, Rota PA, Elkins WR, et al. Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J Infect Dis 1999; 180:950-8.
6. McChesney MB, Miller CJ, Rota PA, et al. Experimental measles. I. Pathogenesis in the normal and the immunized host. Virology 1997; 233:74-84.
7. Shingai M, Inoue N, Okuno T, et al. Wild-type measles virus infection in human CD46/CD150-transgenic mice: CD11c-positive dendritic cells establish systemic viral infection. J Immunol 2005; 175:3252-61.
8. Welstead GG, Iorio C, Draker R, et al. Measles virus replication in lymphatic cells and organs of CD150 (SLAM) transgenic mice. Proc Natl Acad Sci USA 2005; 102:16415-20.
9. Plowright W. Studies on the pathogenesis of Rinderpest in experimental cattle. II. Proliferation of the virus in different tissues following intranasal infection. J Hyg (Lond) 1964; 62:257-81.
10. Appel MJ. Pathogenesis of canine distemper. Am J Vet Res 1969; 30: 1167-82.
11. von Messling V, Milosevic D, Cattaneo R. Tropism illuminated: lymphocyte-based pathways blazed by lethal morbillivirus through the host immune system. Proc Natl Acad Sci USA 2004; 101:14216-21.
12. Takeuchi K, Takeda M, Miyajima N, et al. Stringent requirement for the C protein of wild-type measles virus for growth both in vitro and in macaques. J Virol 2005; 79:7838-44.
13. Joseph BS, Lampert PW, Oldstone MB. Replication and persistence of measles virus in defined subpopulations of human leukocytes. J Virol 1975; 16:1638-49.
14. Esolen LM, Ward BJ, Moench TR, Griffin DE. Infection of monocytes during measles. J Infect Dis 1993; 168:47-52.
15. Grosjean I, Caux C, Bella C, et al. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells. J Exp Med 1997; 186:801-12.
16. Fugier-Vivier I, Servet-Delprat C, Rivailler P, Rissoan MC, Liu YJ, Rabourdin-Combe C. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 1997; 186:813-23.
17. Schnorr J J, Xanthakos S, Keikavoussi P, Kampgen E, ter Meulen V, Schneider-Schaulies S. Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc Natl Acad Sci USA 1997; 94:5326-31.
18. Zilliox MJ, Parmigiani G, Griffin DE. Gene expression patterns in dendritic cells infected with measles virus compared with other pathogens. Proc Natl Acad Sci USA 2006; 103:3363-8.
19. Ito Y, Grivel JC, Chen S, Kiselyeva Y, Reichelderfer P, Margolis L. CXCR4-tropic HIV-1 suppresses replication of CCR5-tropic HIV-1 in human lymphoid tissue by selective induction of CC-chemokines. J Infect Dis 2004; 189:506-14.
20. Glushakova S, Baibakov B, Margolis LB, Zimmerberg J. Infection of human tonsil histocultures: a model for HIV pathogenesis. Nat Med 1995; 1:1320-2.
21. Glushakova S, Baibakov B, Zimmerberg J, Margolis LB. Experimental HIV infection of human lymphoid tissue: correlation of CD4+ T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histocultures inoculated with laboratory strains and patient isolates of HIV type 1. AIDS Res Hum Retroviruses 1997; 13:461-71.
22. Grivel JC, Garcia M, Moss WJ, Margolis LB. Inhibition of HIV-1 replication in human lymphoid tissues ex vivo by measles virus. J Infect Dis 2005; 192:71-8.
23. Riddell MA, Rota JS, Rota PA. Review of the temporal and geographical distribution of measles virus genotypes in the prevaccine and post-vaccine eras. Virol J 2005; 2:87.
24. Minagawa H, Tanaka K, Ono N, Tatsuo H, Yanagi Y. Induction of the measles virus receptor SLAM (CD150) on monocytes. J Gen Virol 2001; 82:2913-7.
25. Devaux P, von Messling V, Songsungthong W, Springfeld C, Cattaneo R. Tyrosine 110 in the measles virus phosphoprotein is required to block STAT protein nuclear translocation. Virology 2007; 360:72-83.
26. Parks CL, Lerch RA, Walpita P, Wang HP, Sidhu MS, Udem SA. Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage. J Virol 2001; 75:910-20.
27. Cocks BG, Chang CC, Carballido JM, Yssel H, de Vries JE, Aversa G. A novel receptor involved in T-cell activation. Nature 1995; 376:260-3.
28. Sidorenko SP, Clark EA. Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes. J Immunol 1993; 151:4614-24.
29. Ohgimoto S, Ohgimoto K, Niewiesk S, et al. The haemagglutinin protein is an important determinant of measles virus tropism for dendritic cells in vitro. J Gen Virol 2001; 82:1835-44.
30. Aversa G, Chang CC, Carballido JM, Cocks BG, de Vries JE. Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. J Immunol 1997; 158: 4036-44.
31. Dorig RE, Marcil A, Chopra A, Richardson CD. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993; 75:295-305.
32. Naniche D, Varior-Krishnan G, Cervoni F, et al. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 1993; 67:6025-32.
33. Yanagi Y, Takeda M, Ohno S. Measles virus: cellular receptors, tropism and pathogenesis. J Gen Virol 2006; 87:2767-79.
34. Radecke F, Spielhofer P, Schneider H, et al. Rescue of measles viruses from cloned DNA. EMBO J 1995; 14:5773-84.
35. Takeda M, Takeuchi K, Miyajima N, et al. Recovery of pathogenic measles virus from cloned cDNA. J Virol 2000; 74:6643-7.
36. Kärber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch Exp Pathol Pharmakol 1931; 162:480-3.
37. Grivel J-C, Margolis LB. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue. Nat Med 1999; 5:344-6.
38. Cathomen T, Naim HY, Cattaneo R. Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J Virol 1998; 72:1224-34.
39. Udem SA. Measles virus: conditions for the propagation and purification of infectious virus in high yield. J Virol Methods 1984; 8:123-36.
40. Schlender J, Schnorr JJ, Spielhofer P, et al. Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro. Proc Natl Acad Sci USA 1996; 93:13194-9.
41. Vongpunsawad S, Oezgun N, Braun W, Cattaneo R. Selectively receptor-blind measles viruses: identification of residues necessary for SLAM-or CD46-induced fusion and their localization on a new hemagglutinin structural model. J Virol 2004; 78:302-13.
42. Roscic-Mrkic B, Schwendener RA, Odermatt B, et al. Roles of macrophages in measles virus infection of genetically modified mice. J Virol 2001; 75:3343-51.
43. Ryon JJ, Moss WJ, Monze M, Griffin DE. Functional and phenotypic changes in circulating lymphocytes from hospitalized Zambian children with measles. Clin Diagn Lab Immunol 2002; 9:994-1003.
44. Schneider-Schaulies S, Dittmer U. Silencing T cells or T-cell silencing: concepts in virus-induced immunosuppression. J Gen Virol 2006; 87: 1423-38.
45. Esolen LM, Park SW, Hardwick JM, Griffin DE. Apoptosis as a cause of death in measles virus-infected cells. J Virol 1995; 69:3955-8.
46. Moench TR, Griffin DE, Obriecht CR, Vaisberg AJ, Johnson RT. Acute measles in patients with and without neurological involvement: distribution of measles virus antigen and RNA. J Infect Dis 1988; 158: 433-42.